Cancer Straight TalkCancer Straight Talk

A Game-Changing Cancer Drug Gives Stage 4 Breast Cancer Patients New Hope

View descriptionShare

For nearly half of all breast cancer patients – those with low levels of the HER2 protein – targeted treatment options have always been limited. Palliative chemo has been the standard of care in stage 4 metastatic patients – until now. In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Shanu Modi, the lead researcher of a groundbreaking MSK trial that proved a drug that combines an antibody with a chemotherapy – trastuzumab deruxtecan (T-DXd) – can control cancer cells and extend survival in stage 4 HER2-low breast cancer patients. With a fresh FDA approval, T-DXd is now being tested on other cancers and changing the way oncologists treat their patients.

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Cancer Straight Talk from MSK

    37 clip(s)

Cancer Straight Talk

Cancer Straight Talk from MSK brings together national experts and cancer patients to have straightf 
Social links
Follow podcast
Recent clips
Browse 37 clip(s)